 | • レポートコード：MRC2Q12-19291 • 出版社/出版日：QYResearch / 2022年12月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥710,500 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,421,000 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、オピオイド鎮痛薬のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 オピオイド鎮痛薬のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 オピオイド鎮痛薬の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 オピオイド鎮痛薬のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのオピオイド鎮痛薬の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のオピオイド鎮痛薬の売上および2028年までの予測に焦点を当てています。 オピオイド鎮痛薬のグローバル主要企業には、Pfizer Inc.、Abbott Laboratories、Johnson & Johnson、Novartis AG、Bayer AG、GlaxoSmithKline plc、F. Hoffmann-La Roche AG、Boehringer Ingelheim International GmbH、Bausch Health、Sanofi S.A.、Teva Pharmaceuticals、Purdue Pharmaceuticals L.P.、Endo International Plc、Assertio Holdings, Incなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 オピオイド鎮痛薬市場は、タイプとアプリケーションによって区分されます。世界のオピオイド鎮痛薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 オキシコンチン、バイコジン、モルヒネ、メタドン、その他 【アプリケーション別セグメント】 外科的疼痛、癌性疼痛、神経因性疼痛、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - オピオイド鎮痛薬製品概要 - タイプ別市場（オキシコンチン、バイコジン、モルヒネ、メタドン、その他） - アプリケーション別市場（外科的疼痛、癌性疼痛、神経因性疼痛、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のオピオイド鎮痛薬販売量予測2017-2028 - 世界のオピオイド鎮痛薬売上予測2017-2028 - オピオイド鎮痛薬の地域別販売量 - オピオイド鎮痛薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別オピオイド鎮痛薬販売量 - 主要メーカー別オピオイド鎮痛薬売上 - 主要メーカー別オピオイド鎮痛薬価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（オキシコンチン、バイコジン、モルヒネ、メタドン、その他） - オピオイド鎮痛薬のタイプ別販売量 - オピオイド鎮痛薬のタイプ別売上 - オピオイド鎮痛薬のタイプ別価格 ・アプリケーション別市場規模（外科的疼痛、癌性疼痛、神経因性疼痛、その他） - オピオイド鎮痛薬のアプリケーション別販売量 - オピオイド鎮痛薬のアプリケーション別売上 - オピオイド鎮痛薬のアプリケーション別価格 ・北米市場 - 北米のオピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別のオピオイド鎮痛薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのオピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別のオピオイド鎮痛薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のオピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別のオピオイド鎮痛薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のオピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別のオピオイド鎮痛薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのオピオイド鎮痛薬市場規模（タイプ別、アプリケーション別） - 主要国別のオピオイド鎮痛薬市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer Inc.、Abbott Laboratories、Johnson & Johnson、Novartis AG、Bayer AG、GlaxoSmithKline plc、F. Hoffmann-La Roche AG、Boehringer Ingelheim International GmbH、Bausch Health、Sanofi S.A.、Teva Pharmaceuticals、Purdue Pharmaceuticals L.P.、Endo International Plc、Assertio Holdings, Inc ・産業チェーン及び販売チャネル分析 - オピオイド鎮痛薬の産業チェーン分析 - オピオイド鎮痛薬の原材料 - オピオイド鎮痛薬の生産プロセス - オピオイド鎮痛薬の販売及びマーケティング - オピオイド鎮痛薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - オピオイド鎮痛薬の産業動向 - オピオイド鎮痛薬のマーケットドライバー - オピオイド鎮痛薬の課題 - オピオイド鎮痛薬の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Opioid Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Opioid Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Opioid Analgesics is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Opioid Analgesics include Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH and Bausch Health, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Opioid Analgesics manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Opioid Analgesics market. Further, it explains the major drivers and regional dynamics of the global Opioid Analgesics market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer Inc.
Abbott Laboratories
Johnson & Johnson
Novartis AG
Bayer AG
GlaxoSmithKline plc
F. Hoffmann-La Roche AG
Boehringer Ingelheim International GmbH
Bausch Health
Sanofi S.A.
Teva Pharmaceuticals
Purdue Pharmaceuticals L.P.
Endo International Plc
Assertio Holdings, Inc
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Opioid Analgesics Segment by Type
OxyContin
Vicodin
Morphine
Methadone
Others
Opioid Analgesics Segment by Application
Surgical Pain
Cancer Pain
Neuropathic Pain
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Opioid Analgesics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Opioid Analgesics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Opioid Analgesics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Opioid Analgesics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Opioid Analgesics sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Opioid Analgesics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Opioid Analgesics sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer Inc., Abbott Laboratories, Johnson & Johnson, Novartis AG, Bayer AG, GlaxoSmithKline plc, F. Hoffmann-La Roche AG, Boehringer Ingelheim International GmbH and Bausch Health, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Opioid Analgesics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Opioid Analgesics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Opioid Analgesics sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Opioid Analgesics Product Introduction
1.2 Market by Type
1.2.1 Global Opioid Analgesics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OxyContin
1.2.3 Vicodin
1.2.4 Morphine
1.2.5 Methadone
1.2.6 Others
1.3 Market by Application
1.3.1 Global Opioid Analgesics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Surgical Pain
1.3.3 Cancer Pain
1.3.4 Neuropathic Pain
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Opioid Analgesics Sales Estimates and Forecasts 2017-2028
2.2 Global Opioid Analgesics Revenue Estimates and Forecasts 2017-2028
2.3 Global Opioid Analgesics Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Opioid Analgesics Sales by Region
2.4.1 Global Opioid Analgesics Sales by Region (2017-2022)
2.4.2 Global Sales Opioid Analgesics by Region (2023-2028)
2.5 Global Opioid Analgesics Revenue by Region
2.5.1 Global Opioid Analgesics Revenue by Region (2017-2022)
2.5.2 Global Opioid Analgesics Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Opioid Analgesics Sales by Manufacturers
3.1.1 Global Top Opioid Analgesics Manufacturers by Sales (2017-2022)
3.1.2 Global Opioid Analgesics Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Opioid Analgesics in 2021
3.2 Global Opioid Analgesics Revenue by Manufacturers
3.2.1 Global Opioid Analgesics Revenue by Manufacturers (2017-2022)
3.2.2 Global Opioid Analgesics Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Opioid Analgesics Revenue in 2021
3.3 Global Opioid Analgesics Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Opioid Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Opioid Analgesics Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Opioid Analgesics Sales by Type
4.1.1 Global Opioid Analgesics Historical Sales by Type (2017-2022)
4.1.2 Global Opioid Analgesics Forecasted Sales by Type (2023-2028)
4.1.3 Global Opioid Analgesics Sales Market Share by Type (2017-2028)
4.2 Global Opioid Analgesics Revenue by Type
4.2.1 Global Opioid Analgesics Historical Revenue by Type (2017-2022)
4.2.2 Global Opioid Analgesics Forecasted Revenue by Type (2023-2028)
4.2.3 Global Opioid Analgesics Revenue Market Share by Type (2017-2028)
4.3 Global Opioid Analgesics Price by Type
4.3.1 Global Opioid Analgesics Price by Type (2017-2022)
4.3.2 Global Opioid Analgesics Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Opioid Analgesics Sales by Application
5.1.1 Global Opioid Analgesics Historical Sales by Application (2017-2022)
5.1.2 Global Opioid Analgesics Forecasted Sales by Application (2023-2028)
5.1.3 Global Opioid Analgesics Sales Market Share by Application (2017-2028)
5.2 Global Opioid Analgesics Revenue by Application
5.2.1 Global Opioid Analgesics Historical Revenue by Application (2017-2022)
5.2.2 Global Opioid Analgesics Forecasted Revenue by Application (2023-2028)
5.2.3 Global Opioid Analgesics Revenue Market Share by Application (2017-2028)
5.3 Global Opioid Analgesics Price by Application
5.3.1 Global Opioid Analgesics Price by Application (2017-2022)
5.3.2 Global Opioid Analgesics Price Forecast by Application (2023-2028)
6 North America
6.1 North America Opioid Analgesics Market Size by Type
6.1.1 North America Opioid Analgesics Sales by Type (2017-2028)
6.1.2 North America Opioid Analgesics Revenue by Type (2017-2028)
6.2 North America Opioid Analgesics Market Size by Application
6.2.1 North America Opioid Analgesics Sales by Application (2017-2028)
6.2.2 North America Opioid Analgesics Revenue by Application (2017-2028)
6.3 North America Opioid Analgesics Market Size by Country
6.3.1 North America Opioid Analgesics Sales by Country (2017-2028)
6.3.2 North America Opioid Analgesics Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Opioid Analgesics Market Size by Type
7.1.1 Europe Opioid Analgesics Sales by Type (2017-2028)
7.1.2 Europe Opioid Analgesics Revenue by Type (2017-2028)
7.2 Europe Opioid Analgesics Market Size by Application
7.2.1 Europe Opioid Analgesics Sales by Application (2017-2028)
7.2.2 Europe Opioid Analgesics Revenue by Application (2017-2028)
7.3 Europe Opioid Analgesics Market Size by Country
7.3.1 Europe Opioid Analgesics Sales by Country (2017-2028)
7.3.2 Europe Opioid Analgesics Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Opioid Analgesics Market Size by Type
8.1.1 Asia Pacific Opioid Analgesics Sales by Type (2017-2028)
8.1.2 Asia Pacific Opioid Analgesics Revenue by Type (2017-2028)
8.2 Asia Pacific Opioid Analgesics Market Size by Application
8.2.1 Asia Pacific Opioid Analgesics Sales by Application (2017-2028)
8.2.2 Asia Pacific Opioid Analgesics Revenue by Application (2017-2028)
8.3 Asia Pacific Opioid Analgesics Market Size by Region
8.3.1 Asia Pacific Opioid Analgesics Sales by Region (2017-2028)
8.3.2 Asia Pacific Opioid Analgesics Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Opioid Analgesics Market Size by Type
9.1.1 Latin America Opioid Analgesics Sales by Type (2017-2028)
9.1.2 Latin America Opioid Analgesics Revenue by Type (2017-2028)
9.2 Latin America Opioid Analgesics Market Size by Application
9.2.1 Latin America Opioid Analgesics Sales by Application (2017-2028)
9.2.2 Latin America Opioid Analgesics Revenue by Application (2017-2028)
9.3 Latin America Opioid Analgesics Market Size by Country
9.3.1 Latin America Opioid Analgesics Sales by Country (2017-2028)
9.3.2 Latin America Opioid Analgesics Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Opioid Analgesics Market Size by Type
10.1.1 Middle East and Africa Opioid Analgesics Sales by Type (2017-2028)
10.1.2 Middle East and Africa Opioid Analgesics Revenue by Type (2017-2028)
10.2 Middle East and Africa Opioid Analgesics Market Size by Application
10.2.1 Middle East and Africa Opioid Analgesics Sales by Application (2017-2028)
10.2.2 Middle East and Africa Opioid Analgesics Revenue by Application (2017-2028)
10.3 Middle East and Africa Opioid Analgesics Market Size by Country
10.3.1 Middle East and Africa Opioid Analgesics Sales by Country (2017-2028)
10.3.2 Middle East and Africa Opioid Analgesics Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Corporation Information
11.1.2 Pfizer Inc. Overview
11.1.3 Pfizer Inc. Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Pfizer Inc. Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Inc. Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Corporation Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Abbott Laboratories Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Corporation Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Johnson & Johnson Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Corporation Information
11.4.2 Novartis AG Overview
11.4.3 Novartis AG Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Novartis AG Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis AG Recent Developments
11.5 Bayer AG
11.5.1 Bayer AG Corporation Information
11.5.2 Bayer AG Overview
11.5.3 Bayer AG Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer AG Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer AG Recent Developments
11.6 GlaxoSmithKline plc
11.6.1 GlaxoSmithKline plc Corporation Information
11.6.2 GlaxoSmithKline plc Overview
11.6.3 GlaxoSmithKline plc Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline plc Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline plc Recent Developments
11.7 F. Hoffmann-La Roche AG
11.7.1 F. Hoffmann-La Roche AG Corporation Information
11.7.2 F. Hoffmann-La Roche AG Overview
11.7.3 F. Hoffmann-La Roche AG Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 F. Hoffmann-La Roche AG Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 F. Hoffmann-La Roche AG Recent Developments
11.8 Boehringer Ingelheim International GmbH
11.8.1 Boehringer Ingelheim International GmbH Corporation Information
11.8.2 Boehringer Ingelheim International GmbH Overview
11.8.3 Boehringer Ingelheim International GmbH Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Boehringer Ingelheim International GmbH Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Boehringer Ingelheim International GmbH Recent Developments
11.9 Bausch Health
11.9.1 Bausch Health Corporation Information
11.9.2 Bausch Health Overview
11.9.3 Bausch Health Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Bausch Health Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bausch Health Recent Developments
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Corporation Information
11.10.2 Sanofi S.A. Overview
11.10.3 Sanofi S.A. Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sanofi S.A. Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi S.A. Recent Developments
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Corporation Information
11.11.2 Teva Pharmaceuticals Overview
11.11.3 Teva Pharmaceuticals Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Teva Pharmaceuticals Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Teva Pharmaceuticals Recent Developments
11.12 Purdue Pharmaceuticals L.P.
11.12.1 Purdue Pharmaceuticals L.P. Corporation Information
11.12.2 Purdue Pharmaceuticals L.P. Overview
11.12.3 Purdue Pharmaceuticals L.P. Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Purdue Pharmaceuticals L.P. Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Purdue Pharmaceuticals L.P. Recent Developments
11.13 Endo International Plc
11.13.1 Endo International Plc Corporation Information
11.13.2 Endo International Plc Overview
11.13.3 Endo International Plc Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Endo International Plc Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Endo International Plc Recent Developments
11.14 Assertio Holdings, Inc
11.14.1 Assertio Holdings, Inc Corporation Information
11.14.2 Assertio Holdings, Inc Overview
11.14.3 Assertio Holdings, Inc Opioid Analgesics Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Assertio Holdings, Inc Opioid Analgesics Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Assertio Holdings, Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Opioid Analgesics Industry Chain Analysis
12.2 Opioid Analgesics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Opioid Analgesics Production Mode & Process
12.4 Opioid Analgesics Sales and Marketing
12.4.1 Opioid Analgesics Sales Channels
12.4.2 Opioid Analgesics Distributors
12.5 Opioid Analgesics Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Opioid Analgesics Industry Trends
13.2 Opioid Analgesics Market Drivers
13.3 Opioid Analgesics Market Challenges
13.4 Opioid Analgesics Market Restraints
14 Key Findings in The Global Opioid Analgesics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
| 【オピオイド鎮痛薬について】 オピオイド鎮痛薬は、主に中枢神経系に作用し、痛みを緩和するために用いられる薬剤の一群を指します。これらの薬剤は、オピオイド受容体と呼ばれる特定の受容体と結合することによって、その効果を発揮します。オピオイド受容体は、脳、脊髄、腸などに分布しており、痛みの知覚や情動、快感の調節に関与しています。本稿では、オピオイド鎮痛薬の定義、特徴、種類、用途、関連技術について詳述いたします。 オピオイド鎮痛薬の定義は、主に合成されたものや天然のオピオイドに基づいた化合物で、強力な鎮痛作用を持つ薬剤のことです。これらは、主に中度から重度の痛みを軽減するために使用されます。オピオイドには、モルヒネ、コデイン、ヒドロモルフォン、オキシコドンなどが含まれ、多くは医師の処方によって使用されます。 オピオイド鎮痛薬の特徴として、まずその強力な鎮痛効果が挙げられます。オピオイドは、痛みの信号を脳に伝達する経路を阻害し、痛みの感覚を軽減します。また、オピオイドは、気分を高揚させる効果もあり、快感をもたらすことから、患者の生活の質を向上させることが期待されます。しかし、これらの利点と同時に、依存症や耐性の形成といった副作用も伴います。 オピオイド鎮痛薬の種類は、一般的にその起源や作用の強さによって分類されます。天然オピオイドには、モルヒネやコデインがあります。モルヒネは、主に強い痛みに使用される薬剤であり、コデインは軽度から中度の痛みを緩和するために用いられます。合成オピオイドには、オキシコドン、ヒドロコドン、フェンタニルなどがあり、これらはモルヒネよりもはるかに強力な鎮痛作用を持つものもあります。 オピオイド鎮痛薬の用途としては、主に慢性的な痛みや急性の痛みの管理が挙げられます。癌性疼痛の緩和、手術後の痛み、外傷による痛みなど、さまざまな状況で用いられます。また、オピオイドは、鎮静効果があり、麻酔剤としての用途もあります。近年では、慢性痛に対するオピオイドの使用が広がっていますが、医療界ではそのリスクも考慮し、慎重な処方が求められています。 関連技術としては、オピオイドの効果を最大限に引き出すための研究が進行中です。これには、持続的な痛み管理を目的とした経皮吸収型のパッチや、注射による投与、またはドラッグデリバリーシステムの開発が含まれます。これらの技術は、患者が感じる痛みをより効果的に管理するために重要です。さらに、オピオイドの副作用を軽減するための新しい薬剤や治療法の開発も進められており、併用療法や非オピオイド系の鎮痛薬との組み合わせが検討されています。 オピオイドに関連する問題の一つは、依存症です。オピオイドは、その快感を伴う性質から、長期間使用していると身体的依存を引き起こす危険性があります。これが売買市場における乱用の原因となり、社会的な問題にも発展しています。このため、医療従事者は、オピオイドを処方する際には、患者のリスクを慎重に評価し、最小限の用量と期間での使用を推奨することが求められています。 また、オピオイドの乱用や過剰摂取を防ぐための施策も重要です。監視システムや、処方時のデータ管理ツール、患者教育プログラムなどが導入されており、これにより適切な使用が促進されています。患者に対する情報提供や、依存症に関する啓発活動は、オピオイドの安全な使用に寄与する重要な要素です。 現代の医学において、オピオイド鎮痛薬は依然として欠かせない存在ですが、その使用には注意が必要です。痛みの管理を目的とした治療の一環として、患者ごとの状況に応じたバランスの取れたアプローチが望まれます。未だに解決すべき課題は多くありますが、研究の進展とともに、より安全で効果的な疼痛管理が実現されることを期待しています。社会全体でオピオイドの問題に対する理解を深め、適切な対策を講じることが必要です。オピオイド鎮痛薬の効果を最大化しつつ、副作用や依存症のリスクを最小化するための医療の進歩は、今後の重要なテーマと言えるでしょう。 |